文献速递针灸推拿中医内科

针灸治疗阿尔茨海默病:系统综述与Meta分析

Acupuncture for Alzheimer's disease: A systematic review and meta-analysis integrating traditional insights and scientific evidence.
PubMed 文献 · J Integr Med · 2026-08-11

该系统综述与Meta分析检索多个数据库至2025年9月,纳入21项RCT共1354例患者,评估针灸治疗阿尔茨海默病的疗效与机制。结果显示针灸可显著改善MMSE认知评分,疗效与多奈哌齐相当,并能调节胆碱能传递和AD相关病理标志物,不良事件轻微短暂。

要点

  • 针灸可显著改善AD患者MMSE评分,疗效与多奈哌齐相当。
  • 常用穴位包括百会、足三里、风池、太冲、丰隆等,局部与远端配穴。
  • 针灸可能通过提升乙酰胆碱、降低Aβ1-40、Aβ1-42和Tau水平发挥作用。

核心结论

  • 针灸作为整体、多靶点疗法对阿尔茨海默病管理具有良好潜力。
  • 针灸在MMSE和ADL方面疗效与多奈哌齐相当,提示非劣效于标准药物治疗。
  • 针灸可调节胆碱能传递和AD相关病理标志物,不良事件轻微短暂。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed、Embase、Cochrane Library、CNKI、维普和万方数据库,覆盖至2025年9月。
  • 纳入21项随机对照试验,共1354例参与者,比较针灸(手针或电针)与假针灸、多奈哌齐、安慰剂或无治疗。
  • 数据由两名评价者独立提取,使用R软件(v4.3.2)的meta和metafor包分析,计算加权均数差(WMD)和95%置信区间(CI)。

主要发现

  • 与无治疗对照相比,针灸显著改善MMSE认知评分(WMD=3.74,95%CI:1.34-6.14)。
  • 与安慰剂对照相比,针灸显著改善MMSE评分(WMD=2.13,95%CI:1.39-2.87)。
  • 针灸在MMSE和ADL方面疗效与多奈哌齐相当,提示非劣效于标准药物治疗。
  • 常用穴位包括GV20、ST36、GB20、LR3、ST40,常结合局部(GV24、EX-HN1)和远端(SP10、KI3)穴位。
  • 报告的不良事件轻微短暂,与对照组无显著差异;生物标志物分析显示针灸提升乙酰胆碱水平,降低血浆Aβ1-40、Aβ1-42和Tau水平。

关键数值与推荐

  • 纳入标准为随机对照试验,比较针灸(手针或电针)与假针灸、多奈哌齐、安慰剂或无治疗。
  • 主要结局包括MMSE和ADL,效应量为WMD及95%CI。

临床怎么用

  • 针灸可作为阿尔茨海默病的一种整体、多靶点治疗选择,尤其适用于不能耐受或不适合标准药物治疗的患者。
  • 临床选穴可参考常用穴位GV20、ST36、GB20、LR3、ST40,并结合局部与远端配穴。
  • 治疗过程中应关注不良事件,但报告显示轻微短暂,与对照无显著差异。

局限性

  • 未来研究需标准化针灸方案,整合中医辨证分型。
  • 需采用神经生物学和影像学技术探索针灸治疗AD的机制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Alzheimer's disease (AD), a leading cause of dementia in the elderly, is characterized by progressive cognitive impairment, and still lacks effective therapeutic interventions. OBJECTIVE: This systematic review synthesizes the classical theoretical foundations, clinical evidence, and modern mechanistic insights for the use of acupuncture to treat AD. SEARCH STRATEGY: A meta-analysis was conducted based on a comprehensive literature search of PubMed, Embase, the Cochrane Library, CNKI, VIP information, and Wanfang Data, covering the period from inception until September 2025. INCLUSION CRITERIA: Eligible randomized controlled trials (RCTs) compared acupuncture (manual or electroacupuncture) with control interventions, including sham acupuncture, donepezil, placebo, or no treatment. DATA EXTRACTION AND ANALYSIS: Data were extracted by two reviewers working independently and then analyzed using the meta and meta for packages in R (v4.3.2). Weighted mean differences (WMDs) and 95% confidence intervals (CIs) were calculated. RESULTS: A total of 21 RCTs comprising 1354 participants met the inclusion criteria. Compared with no-treatment controls, acupuncture significantly improved cognitive performance, as measured by the Mini-Mental State Examination (MMSE) (WMD = 3.74, 95% CI: 1.34-6.14), and outperformed placebo controls (WMD = 2.13, 95% CI: 1.39-2.87). Acupuncture showed efficacy comparable to that of donepezil on MMSE and Activity of Daily Living (ADL), suggesting non-inferiority to standard pharmacotherapy. Frequently used acupoints included GV20, ST36, GB20, LR3, and ST40, often combining local (GV24, EX-HN1) and distal (SP10, KI3) points. Reported adverse events were mild and transient, with no significant difference from controls. Biomarker analyses indicated that acupuncture enhanced acetylcholine levels and reduced plasma Aβ1-40, Aβ1-42, and Tau levels, implying modulation of cholinergic transmission and AD-related pathology. CONCLUSION: This review highlights acupuncture as a holistic, multi-targeted therapy with promising potential for managing AD. Future research should aim to standardize acupuncture protocols, integrate TCM syndrome differentiation, and adopt neurobiological and imaging techniques to explore mechanisms. Please cite this article as: Huang WL, Wang LL, Shi JR, Liu Q. Acupuncture for Alzheimer's disease: A systematic review and meta-analysis integrating traditional insights and scientific evidence. J Integr Med. 2026; Epub ahead of print.

来源:J Integr Med,查看原文。版权归原作者所有。

引用

  1. Huang WL, Wang LL, Shi JR, et al. Acupuncture for Alzheimer's disease: A systematic review and meta-analysis integrating traditional insights and scientific evidence. J Integr Med. 2026. PMID: 42665452. doi:10.1016/j.joim.2026.08.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。